Eli Lilly’s Reyvow Struggles to Gain Ground in the Acute Segment of the US Migraine Market, Overshadowed by AbbVie’s Ubrelvy and Biohaven’s Nurtec ODT, According to Spherix Global Insights
EXTON, Pa., June 30, 2020 /PRNewswire/ -- The number of companies active in the migraine space continues to expand, with Biohaven...